Clinical Trial Update: Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing somapacitan with placebo and daily somatropin in adults with growth hormone deficiency has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• NNC0195-0092 (Somapacitan) (somapacitan)
• Norditropin FlexPro (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07